52,648 Shares in The Clorox Company $CLX Bought by First Nebraska Trust Co

First Nebraska Trust Co purchased a new position in The Clorox Company (NYSE:CLX) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 52,648 shares of the company’s stock, valued at approximately $5,456,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Clorox by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after buying an additional 514 shares in the last quarter. Woodline Partners LP boosted its holdings in Clorox by 253.7% in the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after acquiring an additional 7,465 shares in the last quarter. Baird Financial Group Inc. boosted its holdings in Clorox by 1.7% in the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after acquiring an additional 424 shares in the last quarter. Jump Financial LLC grew its stake in Clorox by 173.5% in the second quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after acquiring an additional 7,924 shares during the period. Finally, Bank of Nova Scotia grew its stake in Clorox by 26.2% in the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after acquiring an additional 3,352 shares during the period. 78.53% of the stock is owned by institutional investors.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber purchased 5,000 shares of the stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.63% of the company’s stock.

Clorox Stock Performance

Shares of CLX opened at $95.66 on Friday. The firm has a market capitalization of $11.57 billion, a P/E ratio of 15.53 and a beta of 0.54. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $128.90. The stock has a 50 day moving average price of $95.51 and a two-hundred day moving average price of $103.67. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter last year, the company earned $1.45 earnings per share. Equities analysts forecast that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Citigroup decreased their price objective on Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a report on Friday, May 1st. The Goldman Sachs Group reiterated a “sell” rating and issued a $83.00 target price on shares of Clorox in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $94.00 price target on shares of Clorox in a research report on Wednesday, July 22nd. Jefferies Financial Group downgraded shares of Clorox from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $125.00 to $98.00 in a report on Tuesday. Finally, Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Twelve analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat.com, Clorox presently has an average rating of “Reduce” and a consensus price target of $101.00.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.